These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 38546116)

  • 1. Lanthanum hydroxide protects kidney through gut microbiota in a rat model of chronic kidney disease.
    Gao Y; Wang S; Sun L; Li B; Liu H; Bu R; Su C; Guo M; Liu Y; Zhao L; Gu C; Li X; Yuan X; Wang Q; Li G
    Pharmacol Res Perspect; 2024 Apr; 12(2):e1187. PubMed ID: 38546116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal Adenine-Induced Chronic Kidney Disease Programs Hypertension in Adult Male Rat Offspring: Implications of Nitric Oxide and Gut Microbiome Derived Metabolites.
    Hsu CN; Yang HW; Hou CY; Chang-Chien GP; Lin S; Tain YL
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33008046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change.
    Liu Y; Li J; Yu J; Wang Y; Lu J; Shang EX; Zhu Z; Guo J; Duan J
    J Pharm Biomed Anal; 2018 Feb; 149():425-435. PubMed ID: 29169110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease.
    Feng YL; Cao G; Chen DQ; Vaziri ND; Chen L; Zhang J; Wang M; Guo Y; Zhao YY
    Cell Mol Life Sci; 2019 Dec; 76(24):4961-4978. PubMed ID: 31147751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synbiotics Alleviate the Gut Indole Load and Dysbiosis in Chronic Kidney Disease.
    Yang CY; Chen TW; Lu WL; Liang SS; Huang HD; Tseng CP; Tarng DC
    Cells; 2021 Jan; 10(1):. PubMed ID: 33435396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiome in Chronic Kidney Disease (CKD): An Omics Perspective.
    Lohia S; Vlahou A; Zoidakis J
    Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on the mechanism of hirudin multi target delaying renal function decline in chronic kidney disease based on the "gut-kidney axis" theory.
    Long C; Zhang C; Xie Y
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Oct; 397(10):7951-7962. PubMed ID: 38758227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical impact of gut microbiota in chronic kidney disease.
    Kim SM; Song IH
    Korean J Intern Med; 2020 Nov; 35(6):1305-1316. PubMed ID: 32872729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.
    Rukavina Mikusic NL; Kouyoumdzian NM; Choi MR
    Pflugers Arch; 2020 Mar; 472(3):303-320. PubMed ID: 32064574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats.
    Sueyoshi M; Fukunaga M; Mei M; Nakajima A; Tanaka G; Murase T; Narita Y; Hirata S; Kadowaki D
    Clin Exp Nephrol; 2019 Jul; 23(7):908-919. PubMed ID: 30895529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blueberry, cranberry, raspberry, and strawberry as modulators of the gut microbiota: target for treatment of gut dysbiosis in chronic kidney disease? From current evidence to future possibilities.
    Coutinho-Wolino KS; Melo MFS; Mota JC; Mafra D; Guimarães JT; Stockler-Pinto MB
    Nutr Rev; 2024 Jan; 82(2):248-261. PubMed ID: 37164634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of gut microbiota: How it could play roles beyond the digestive system on development of cardiovascular and renal diseases.
    Suganya K; Son T; Kim KW; Koo BS
    Microb Pathog; 2021 Mar; 152():104583. PubMed ID: 33164814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD.
    Barba C; Soulage CO; Caggiano G; Glorieux G; Fouque D; Koppe L
    Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33255454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of gut microbiota in patients with stage 3-4 chronic kidney disease: a retrospective cohort study.
    Yang X; Cai S; Gong J; Zhang J; Lian M; Chen R; Zhou L; Bai P; Liu B; Zhuang M; Tan H; Xu J; Li M
    Int Urol Nephrol; 2024 May; 56(5):1751-1762. PubMed ID: 38085410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. POTENTIAL THERAPEUTIC OPTIONS TARGETING THE GUT DYSBIOSIS IN CHRONIC KIDNEY DISEASE.
    Dobrek Ł
    Wiad Lek; 2022; 75(7):1757-1764. PubMed ID: 35962694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Link between gut microbiota dysbiosis and chronic kidney disease.
    Noce A; Marchetti M; Marrone G; Di Renzo L; Di Lauro M; Di Daniele F; Albanese M; Di Daniele N; De Lorenzo A
    Eur Rev Med Pharmacol Sci; 2022 Mar; 26(6):2057-2074. PubMed ID: 35363356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease.
    Taguchi K; Fukami K; Elias BC; Brooks CR
    Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34069405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing the gut microbiota in patients with chronic kidney disease.
    Hu X; Ouyang S; Xie Y; Gong Z; Du J
    Postgrad Med; 2020 Aug; 132(6):495-505. PubMed ID: 32241215
    [No Abstract]   [Full Text] [Related]  

  • 19. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients.
    Xu KY; Xia GH; Lu JQ; Chen MX; Zhen X; Wang S; You C; Nie J; Zhou HW; Yin J
    Sci Rep; 2017 May; 7(1):1445. PubMed ID: 28469156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huang Gan Formula Alleviates Systemic Inflammation and Uremia in Adenine-Induced Chronic Kidney Disease Rats May Associate with Modification of Gut Microbiota and Colonic Microenvironment.
    Zhao J; Zhao C; Xun T; Wang X; Wei S; Ye C; Zhang M; Guo D; Yang X
    Drug Des Devel Ther; 2024; 18():13-28. PubMed ID: 38205394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.